Improved survival in advanced Hodgkin's disease with the use of combined modality therapy
- 1 September 1990
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 19 (3), 535-542
- https://doi.org/10.1016/0360-3016(90)90478-3
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease.Journal of Clinical Oncology, 1987
- Decreasing Risk of Leukemia with Prolonged Follow-up after Chemotherapy and Radiotherapy for Hodgkin's DiseaseNew England Journal of Medicine, 1987
- Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's DiseaseAnnals of Internal Medicine, 1986
- BCVPP Chemotherapy for Advanced Hodgkin's Disease: Evidence for Greater Duration of Complete Remission, Greater Survival, and Less Toxicity Than with a MOPP RegimenAnnals of Internal Medicine, 1984
- Risk of leukemia in patients treated for Hodgkin's diseaseEuropean Journal of Cancer and Clinical Oncology, 1982
- Treatment of advanced untreated Hodgkin's disease with SCAB—an alternative to MOPPCancer, 1981
- Curability of Advanced Hodgkin's Disease with ChemotherapyAnnals of Internal Medicine, 1980
- SECOND MALIGNANCIES COMPLICATING HODGKIN'S DISEASE IN REMISSIONThe Lancet, 1975
- Combination Chemotherapy in Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1973
- Theoretical considerations in combinations of localized and systemic therapy for neoplastic diseaseJournal of Theoretical Biology, 1972